SELLAS Life Sciences Group, Inc(NASDAQ:SLS) 
SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. The company's lead product candidate is galinpepimut-S (GPS), a wilms tumor 1 targeting peptide-based cancer immun...
Website: http://www.sellaslifesciences.com
Full Time Employees: 5
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 1.07
H 1.09
L 1.02
C 1.04
V 1,316,312
10EMA 1.04
20EMA 1.04
60EMA 1.04
120EMA 1.04
250EMA 1.04